Mankind Pharma announces IPO price band at Rs 1,026-1,080 https://ift.tt/VT6WGId the upper end of the price band, the fourth largest pharmaceutical company in terms of domestic sales will be valued at ₹43,264 crore. The four-crore share IPO will be entirely an offer-for-sale (OFS) where existing shareholders will offload a portion of their stakes.
Government's cash surplus tops Rs 3.4 lakh crore https://ift.tt/54P3HSG from the deceleration in government spending, higher direct tax collections and a likely sharp rise in issuances of Treasury Bills by the Centre in FY24 were factors pushing up the government's cash balances, analysts said. The flow of government cash balances to and from the banking system is a key factor that influences liquidity conditions.
Comments
Post a Comment